The University of Oklahoma Health Sciences Center (OUHSC) and the NCI-Designated Stephenson Cancer Center (SCC) tag teamed on a “double feature”–sponsoring the recent 2019 END2Cancer conference at the Samis Education Center on the OUHSC campus while presenting to 200 cancer research scientists. The main event included updates from oncology researchers about their progress in pursuing breakthrough discoveries in the area of cancer treatment with a focus on emerging nanotechnology and cancer drug delivery applications. In parallel, OU showcased its Stephenson Cancer Center on the Health Sciences Campus.
Putting Oklahoma on the Map
Although not a state generally well-known for life science-focused innovative, state-of-the-art cancer research in Oklahoma drives considerable research productivity with OUHSC as a critical hub of medical research innovation. TrialSite News has covered an ongoing impressive track record of the Oklahoma Medical Research Foundation, for example. They have generated many patents and spinoff life science-based ventures over the years.
Rajagopal Ramesh, PhD, conference chair and professor, Department of Pathology at the University of Oklahoma College of Medicine acknowledged that putting “Oklahoma on the map and have the Stephenson Cancer Center recognizes for great science” was an important underlying objective. After all, they are very active in the research of advances in diagnosis and treatment of cancer. Oklahoma’s NCI-Designated Stephenson Cancer Centers ranks in the top 50 in the nation for cancer care in the 2019-2020 U.S. News & World Report and ranks number 1 among call cancer centers in the nation for the number of patients participating in clinical trials, reports The Oklahoman.
University of Oklahoma Stephenson Cancer Center
The Stephenson Cancer Center, formerly known as the OU Cancer Institute, is located on the University of Oklahoma Health Sciences Center campus in Oklahoma City. The center’s mission centers on the promotion and support of cancer research, education, care and patient support for Oklahomans and beyond. In 2018, the Stephenson Cancer Center was officially awarded NCI Designation, becoming the first in Oklahoma to do so.
Rajagopal Ramesh, PhD, professor, Department of Pathology at the University of Oklahoma College of Medicine
Call to Action: Although TrialSite News cannot independently verify, The Oklahoman claimed that the Stephenson Cancer Center ranks number 1 nationwide in patient participation in clinical trials. This is a material data point that industry sponsors and CROs should note.